Cover storyContinued Process Verification In Pharma: What Literature Shows
CPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.
Cover storyCPV theory is well understood, but literature shows execution is uneven, here's what real-world data reveals about running Stage 3 well.

Teva is negotiating a Medicaid pricing deal with the Trump administration, with implications for generics supply contracts and volume planning across the sector.

AstraZeneca closes Dizal acquisition, gaining global control of lung cancer drug Zegfrovy and triggering GMP integration obligations across its manufacturing network.
Teva's TEV '408 met its primary endpoint in a Phase 2a celiac study, preventing gluten-induced intestinal damage after a single subcutaneous dose.

Evotec and Plectonic combine BiTco and LOGIBODY® platforms in a preclinical collaboration targeting T cell engager limitations in solid tumors.
Latest edition

Sep 28
Feb 03From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
